Abstract: Systems and methods are disclosed to enable determining thermal protection characteristics of an integrated circuit. In one embodiment, an integrated circuit includes a proportional to absolute temperature (PTAT) generator that provides a PTAT signal that varies as a function of temperature. Thermal protection control system provides an output signal indicative of a thermal protection condition based at least in part on the PTAT signal. A monitoring system that provides a path to enable selective measuring of at least one signal associated with operation of the thermal protection control system.

Abstract: A first fluid connector is provided for selective interconnection to and fluid transfer with a second fluid connector. The first connector comprises a fluid passageway, an internal member and an outer collar supportably disposed about the internal member for selective advancement and retraction relative thereto. At least a portion of the fluid passageway may extend through the internal member. The outer collar may be selectively retracted to facilitate cleaning of the internal member. In some embodiments, the outer collar and internal member may be disposed so that a distal portion of the internal member is substantially flush with or a distal portion of internal member projects beyond a distal end of the outer collar when the outer collar is in a retracted position relative thereto. To facilitate cleaning, a distal end or distal portion of the internal member may be substantially closed when the first and second connectors are disconnected.

Abstract: A power converter receiving a single-sided supply which is ground-terminated and providing a regulated positive supply and a regulated negative supply that is optimized to the expected output range of a class AB amplifier, as well as providing excellent efficiency. The converter finds application as a compact converter to power an audio amplifier driving an audio device which is ground terminated, such as a speaker.

Abstract: Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.

Abstract: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed.

Abstract: A hierarchical structure is provided. The hierarchical structure includes object items (301-306) for objects (101-106) located in the hierarchical structure, each object item (301-306) having a name and a link (321-326). The hierarchical structure also includes node items (311-314) each having a name of a hierarchical path name. A node item (311-314) is provided for each unique path name in the hierarchical structure and the link (321-326) of an object item (301-306) links to a single node item (311-314) having the hierarchical path name of the object (101-106).

Abstract: A self test (ST) ground fault circuit interrupter (GFCI) provides a half wave rectifier for powering circuitry for determining and annunciating end of life (EOL) of the GFCI regardless of a shorted diode bridge or opening of a printed circuit board (PCB) trace. A fuse resistor is provided to open before an open PCB trace can occur. A microprocessor-controlled heat-conducting circuit is provided adjacent to a thermal fuse to controllably open the thermal fuse and remove power from face receptacle contacts and load terminals when EOL occurs.

Abstract: The invention is directed to increasing the endurance of a tire by providing an oxidation shield strip located in the vicinity of a critical area of the tire. The oxidation shield strip acts as a local oxygen diffusion barrier.

Abstract: Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula IA.

Abstract: A method evaluating threshold of a data cell in a memory device including a programming locus coupled with the data cell for receiving a programming signal setting a stored signal level in the data cell and responding to a read signal to indicate the stored signal at a read locus; includes the steps of: (a) in no particular order: (1) selecting a test threshold signal; and (2) setting a read signal at a non-read level; (b) applying the test threshold signal to the programming locus; (c) cycling the read signal between a read level and a non-read level while applying the test threshold signal to the programming locus to present at least two test signals at the read locus when the read signal is at the read level; and (d) while cycling, observing whether the at least two test signals manifest a difference greater than a predetermined amount.

Abstract: A system and method are provided for determining an expected life of an electric surge protection component. The system and method monitors preferably each surge that an electric surge protection component experiences. Each surge is measured to determine magnitude and duration, and a cumulative surge measurement history is maintained for each component. Based upon an analysis of the cumulative surge measurement history, an expected life of the component is determined, and an end user is alerted at or preferably near an end of the expected life of the device.

Abstract: Compounds that selectively inhibit the binding of ligands to ?4?1 integrin (VLA-4) and methods for their preparation are disclosed. In one embodiment, compounds of the invention are represented by Formula I: As selective inhibitors of VLA-4 mediated cell adhesion, compounds of the present invention are useful in the treatment of conditions associated with such adhesion, including, but not limited to, such conditions as inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting VLA-4 mediated cell adhesion and methods of treating conditions associated with LA-4 mediated cell adhesion.

Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non-limiting example(s) include, psoriasis), autoimmune diseases (non-limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non-limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.

Abstract: A self test (ST) ground fault circuit interrupter (GFCI) provides improved end of life (EOL) detection by rejecting false EOL information. A processing device receives fault detection signals indicating when faults are detected, and input signals indicating when contacts used to interrupt power to a load are closed. The processing device rejects the fault detection signals when they fail to meet a selected condition and the contacts are closed, and declares end of life (EOL) when the selected condition is met. The fault detection signals can correspond to pulses at an output of a gated device between the processing device and a GFCI chip, and the selected condition can be a selected integer number of pulses.

Abstract: A self testing fault detector having a line side and a load side and a conductive path there between. The apparatus includes a solenoid, which is adapted to move a plurality of contacts disposed in the conductive path from a first position to a second position when the self testing device is powered from the line side; and a processor, which is adapted to energize the solenoid using a first switch and maintain said solenoid in the energized state using a second switch.

Abstract: There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Abstract: Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.

Abstract: A bias device that modifies the bias of a device based on an input signal to the device. The device may have a fixed bias, and the bias device can be connected in parallel with the fixed bias. The device can be an amplifier, such as a linear amplifier or a class AB amplifier. The bias device can be configured to provide maximum bias during the device's crossover time period.

Abstract: A self testing fault detector having a line side and a load side and a conductive path there between, said apparatus is provided. The self testing fault detector includes a controller, adapted to perform periodic status tests on a protection circuit of the self testing fault detector without interrupting power to the load.

Abstract: A method for calling a software method in a called CORBA application by a caller software method in a caller CORBA application in a process of a computer system is disclosed. The caller software method calls a software method in a CORBA stub sending a parameter which is created using a classloader of the caller application. The CORBA stub software method calls a software method in a dynamic proxy sending the parameter. The dynamic proxy software method calls an ORB sending the parameter. The ORB serializes the parameter and returns it to the dynamic proxy software method. The dynamic proxy software method calls the ORB sending the serialized parameter. The ORB deserializes the serialized parameter using a classloader of the called application and returns it to the dynamic proxy software method. The dynamic proxy software method calls the called software method sending the deserialized parameter.